FindTrial
Sign In

Clinical efficacy of ciprofol and propofol anesthesia in patients with pancreatic cancer

Clinical efficacy of ciprofol and propofol anesthesia in patients with pancreatic cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090705
Enrollment
Unknown
Registered
2024-10-12
Start date
2024-10-15
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer

Interventions

ciprofol group:None
propofol group:None

Sponsors

The First Hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients who have complete clinical data and use ciprofol or propofol for maintenance of general anesthesia; Patients aged 18 years or older.

Exclusion criteria

Exclusion criteria: General anesthetic mixed with maintenance drugs with inhalation anesthetics; Patients with other systemic tumor history and incomplete basic data.

Design outcomes

Primary

MeasureTime frame
perioperative complications ;—

Secondary

MeasureTime frame
Overall postoperative survival time;Postoperative metastasis rate;—

Countries

China

Contacts

Public ContactFangfang Han

The First Hospital of Lanzhou University

hanff20@lzu.edu.cn+86 182 1971 2389

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026